Biophytis hosted a virtual key opinion leader (KOL) event on October 6th, 2021, on its lead projects, Sarconeos (BIO101) for the treatment of COVID-19 and Sarcopenia.
- For the COVA study with Sarconeos (BIO101) in COVID-19:
- Professor Suzana Margareth Ajeje Lobo, MD, Hospital de Base Da Faculdade de Medicina de São José Do Rio Preto, São Paulo State, Brazil
- Dr Girish Balachandran Nair, MD, Associate Professor of Medicine in the division of Pulmonary and Critical Care, Medical Director of the Interstitial Lung Disease (ILD) program and the Associate Program Director for the Pulmonary and Critical Care Fellowship at Beaumont Hospital in Royal Oak, USA
- For the SARA study with Sarconeos (BIO101) in Sarcopenia:
- Professor Bruno Vellas, MD, PhD, Chair of the Gerontopole at the University of Toulouse in France
- Dr Roger A. Fielding, Ph.D., Associate Center Director, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Director and Senior Scientist, Nutrition, Exercise Physiology, and Sarcopenia Laboratory, Professor of Nutrition and Medicine, Friedman School of Nutrition Science and Policy, Tufts University School of Medicine as well as Associate Director, Boston Claude D. Pepper Older Americans Independence Center Boston, MA
REPLAY KOL ABOUT COVA STUDY
Biophytis representatives: Stanislas Veillet (CEO), Evelyne Nguyen (CFO) and Rob Van Maanen (CMO)
REPLAY KOL ABOUT SARA STUDY
Biophytis representatives: Stanislas Veillet (CEO), Evelyne Nguyen (CFO) and Jean Mariani (Scientific Board Director)